Dimitrí Semizarov

Title: The Innovations of Dimitrí Semizarov

Introduction

Dimitrí Semizarov is an accomplished inventor based in Chicago, IL. He has made significant contributions to the field of cancer therapy through his innovative research and patent work. His expertise lies in the development of biomarkers that aid in the classification of cancer patients for targeted therapies.

Latest Patents

Dimitrí holds a patent for "Biomarkers for identifying patient classes." This patent discloses methods for classifying a patient with cancer as a candidate for therapy with a Bcl-2 family inhibitor. The process involves determining the level of at least one biomarker in a sample and comparing it to a threshold level. Additionally, the patent describes methods for identifying classes of patients with refractory cancer for second-line therapy using a Bcl-2 family inhibitor.

Career Highlights

Dimitrí Semizarov is currently employed at AbbVie Inc., a leading biopharmaceutical company. His work focuses on advancing cancer treatment options and improving patient outcomes through innovative biomarker research. With a patent portfolio that includes 1 patent, he continues to contribute to the scientific community.

Collaborations

Dimitrí has collaborated with notable colleagues, including Evelyn M McKeegan and Barry Lee Dowell. These partnerships have fostered a collaborative environment that enhances research and development efforts in the field of oncology.

Conclusion

Dimitrí Semizarov's work exemplifies the impact of innovation in cancer therapy. His contributions through patents and collaborations are paving the way for more effective treatment options for patients.